![A 12-Day Course of Imiquimod 5% for the Treatment of Actinic Keratosis: Effectiveness and Local Reactions - ScienceDirect A 12-Day Course of Imiquimod 5% for the Treatment of Actinic Keratosis: Effectiveness and Local Reactions - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1578219018300192-gr1.jpg)
A 12-Day Course of Imiquimod 5% for the Treatment of Actinic Keratosis: Effectiveness and Local Reactions - ScienceDirect
![How to use fluorouracil and imiquimod as treatments for non melanoma skin cancer in a general practice setting - Best Practice Advocacy Centre New Zealand How to use fluorouracil and imiquimod as treatments for non melanoma skin cancer in a general practice setting - Best Practice Advocacy Centre New Zealand](https://bpac.org.nz/2017/img/imiquimod-aks-severe.jpg)
How to use fluorouracil and imiquimod as treatments for non melanoma skin cancer in a general practice setting - Best Practice Advocacy Centre New Zealand
![The ophthalmic side-effects of imiquimod therapy in the management of periocular skin lesions | British Journal of Ophthalmology The ophthalmic side-effects of imiquimod therapy in the management of periocular skin lesions | British Journal of Ophthalmology](https://bjo.bmj.com/content/bjophthalmol/95/12/1682/F1.large.jpg)
The ophthalmic side-effects of imiquimod therapy in the management of periocular skin lesions | British Journal of Ophthalmology
![How to use fluorouracil and imiquimod as treatments for non melanoma skin cancer in a general practice setting - Best Practice Advocacy Centre New Zealand How to use fluorouracil and imiquimod as treatments for non melanoma skin cancer in a general practice setting - Best Practice Advocacy Centre New Zealand](https://bpac.org.nz/2017/img/imiquimod-aks-mild.jpg)
How to use fluorouracil and imiquimod as treatments for non melanoma skin cancer in a general practice setting - Best Practice Advocacy Centre New Zealand
![Imiquimod Induces Sustained Remission of Actinic Damage: A Case Report Spanning One Decade of Observation | MDedge Dermatology Imiquimod Induces Sustained Remission of Actinic Damage: A Case Report Spanning One Decade of Observation | MDedge Dermatology](https://cdn.mdedge.com/files/s3fs-public/images/RTEmagicC_CT095020020-e_Fig2B.jpg.jpg)
Imiquimod Induces Sustained Remission of Actinic Damage: A Case Report Spanning One Decade of Observation | MDedge Dermatology
![PDF] Visualization and Treatment of Subclinical Actinic Keratoses with Topical Imiquimod 5% Cream: An Observational Study | Semantic Scholar PDF] Visualization and Treatment of Subclinical Actinic Keratoses with Topical Imiquimod 5% Cream: An Observational Study | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/bc09564aef48b18237eb8bddd75404f5e098d283/2-Figure1-1.png)
PDF] Visualization and Treatment of Subclinical Actinic Keratoses with Topical Imiquimod 5% Cream: An Observational Study | Semantic Scholar
![Local and systemic adverse effects of imiquimod therapy for external anogenital warts in men: report of three cases | Semantic Scholar Local and systemic adverse effects of imiquimod therapy for external anogenital warts in men: report of three cases | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/99a7d3af12663f7b11546efaa346ac2175192e41/2-Figure1-1.png)
Local and systemic adverse effects of imiquimod therapy for external anogenital warts in men: report of three cases | Semantic Scholar
![PDF] Safety, efficacy, and patient acceptability of imiquimod for topical treatment of actinic keratoses | Semantic Scholar PDF] Safety, efficacy, and patient acceptability of imiquimod for topical treatment of actinic keratoses | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/a8445eee9bab1f0f93099fbbf750f0c4d4c4bc51/5-Figure3-1.png)
PDF] Safety, efficacy, and patient acceptability of imiquimod for topical treatment of actinic keratoses | Semantic Scholar
![Series of Fourteen Cases of Topical Imiquimod 5% in Lentigo Maligna: Treatment Modalities and Clues for Detecting Recurrences | Actas Dermo-Sifiliográficas Series of Fourteen Cases of Topical Imiquimod 5% in Lentigo Maligna: Treatment Modalities and Clues for Detecting Recurrences | Actas Dermo-Sifiliográficas](https://multimedia.elsevier.es/PublicationsMultimediaV1/item/multimedia/S0001731022001971:gr1.jpeg?xkr=ue/ImdikoIMrsJoerZ+w91sAmkCw32Jed9sZf6jzEuDbFpW7G0NfARZs8afh+9K8v8RN+oFy2ZmalFHXVYo6ApZGyZ/fn2bSHPkVus7bbA0mWwJSwHCbAp5KUiOGjd7JSll38/Ha3U11soN+AZWy8HQ1CbESnAN3TLHeBBORerYb94uLnzOUGPIQ18n1a0R17dPNzDUsfP+BwfQtiz7ph8uj0RK8zC9bjm0v2NKslMGSItcK4IQNaSB0JfpZMLexu0WwoP5E9rZiiEMNKerNKGz2QGWXGXpCvZNvlXsWeVc=)
Series of Fourteen Cases of Topical Imiquimod 5% in Lentigo Maligna: Treatment Modalities and Clues for Detecting Recurrences | Actas Dermo-Sifiliográficas
![Twelve-week Treatment of Lentigo Maligna with Imiquimod Results in a High and Sustained Clearance Rate | HTML | Acta Dermato-Venereologica Twelve-week Treatment of Lentigo Maligna with Imiquimod Results in a High and Sustained Clearance Rate | HTML | Acta Dermato-Venereologica](https://www.medicaljournals.se/acta/content_files/files/web/4168-web-resources/image/9219.png)
Twelve-week Treatment of Lentigo Maligna with Imiquimod Results in a High and Sustained Clearance Rate | HTML | Acta Dermato-Venereologica
![Imiquimod Induces Sustained Remission of Actinic Damage: A Case Report Spanning One Decade of Observation | MDedge Dermatology Imiquimod Induces Sustained Remission of Actinic Damage: A Case Report Spanning One Decade of Observation | MDedge Dermatology](https://cdn.mdedge.com/files/s3fs-public/images/RTEmagicC_CT095020020-e_Fig1.jpg.jpg)